IRIDEX CORP Files 8-K on Financials
Ticker: IRIX · Form: 8-K · Filed: Apr 14, 2025 · CIK: 1006045
| Field | Detail |
|---|---|
| Company | Iridex Corp (IRIX) |
| Form Type | 8-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, results-of-operations
Related Tickers: IRIX
TL;DR
IRIDEX CORP filed an 8-K on 4/14/25 detailing financial results and condition.
AI Summary
On April 14, 2025, IRIDEX CORP filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as financial statements and exhibits. The report was filed as of April 14, 2025, with the SEC.
Why It Matters
This filing provides investors with updated information regarding IRIDEX CORP's financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediately alarming or significant new information.
Key Players & Entities
- IRIDEX CORP (company) — Registrant
- 0000950170-25-053714 (filing_id) — Accession Number
- April 14, 2025 (date) — Filing Date
- 1212 Terra Bella Avenue, Mountain View, California 94043 (address) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
When was this 8-K filing submitted to the SEC?
The filing was submitted on April 14, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 1212 Terra Bella Avenue, Mountain View, California 94043.
What is the Commission File Number for IRIDEX CORP?
The Commission File Number for IRIDEX CORP is 000-27598.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding IRIDEX CORP (IRIX).